{"data":[{"accessionNo":"0001699737-26-000021","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":"69353Y103","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-09-02","reportingPerson":"Srinivas Akkaraju","reportingCik":null,"personType":"IN","sharesOwned":7577467,"percentOfClass":9.9,"filedAt":"2026-09-15","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0001699737-26-000021","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":"69353Y103","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-09-02","reportingPerson":"Samsara Opportunity Fund GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":3788733,"percentOfClass":5,"filedAt":"2026-09-15","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0001699737-26-000021","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":"69353Y103","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-09-02","reportingPerson":"Samsara Opportunity Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":3788733,"percentOfClass":5,"filedAt":"2026-09-15","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0001699737-26-000021","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":"69353Y103","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-09-02","reportingPerson":"Samsara BioCapital GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":3788734,"percentOfClass":5,"filedAt":"2026-09-15","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0001699737-26-000021","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":"69353Y103","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-09-02","reportingPerson":"Samsara BioCapital, L.P.","reportingCik":null,"personType":"PN","sharesOwned":3788734,"percentOfClass":5,"filedAt":"2026-09-15","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0001214659-26-009110","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":"69353Y103","securityClass":"Common stock, par value $0.00001 per share","eventDate":"2026-06-30","reportingPerson":"Sio Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":2634137,"percentOfClass":4.94,"filedAt":"2026-07-28","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0001172661-26-002568","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":"69353Y103","securityClass":"Common stock, par value $0.00001","eventDate":"2026-06-30","reportingPerson":"ArrowMark Colorado Holdings, LLC","reportingCik":null,"personType":"IA","sharesOwned":1959579,"percentOfClass":3.67,"filedAt":"2026-07-10","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0001012975-26-000440","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":"69353Y103","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-03-31","reportingPerson":"Euclidean Capital LLC","reportingCik":null,"personType":"OO","sharesOwned":2627643,"percentOfClass":4.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0001012975-26-000440","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":"69353Y103","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-03-31","reportingPerson":"Ashvin B. Chhabra","reportingCik":null,"personType":"IN","sharesOwned":2627643,"percentOfClass":4.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0001012975-26-000440","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":"69353Y103","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-03-31","reportingPerson":"Marilyn H. Simons","reportingCik":null,"personType":"IN","sharesOwned":2627643,"percentOfClass":4.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0001012975-26-000440","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":"69353Y103","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-03-31","reportingPerson":"Greenland NFP B Ltd.","reportingCik":null,"personType":"OO","sharesOwned":1300818,"percentOfClass":2.4,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0001012975-26-000440","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":"69353Y103","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-03-31","reportingPerson":"Greenland A LLC","reportingCik":null,"personType":"OO","sharesOwned":346884,"percentOfClass":0.7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0001012975-26-000440","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":"69353Y103","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-03-31","reportingPerson":"Symmetry Group Ltd.","reportingCik":null,"personType":"OO","sharesOwned":247203,"percentOfClass":0.5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0001012975-26-000440","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":"69353Y103","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-03-31","reportingPerson":"Greenland NFP LLC","reportingCik":null,"personType":"OO","sharesOwned":66300,"percentOfClass":0.1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0001214659-26-005496","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":"69353Y103","securityClass":"Common stock, par value $0.00001 per share","eventDate":"2026-03-31","reportingPerson":"Sio Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":3076580,"percentOfClass":5.77,"filedAt":"2026-05-04","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0000947871-26-000231","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2026-03-02","reportingPerson":"ORBIMED ADVISORS LLC","reportingCik":"0001055951","personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-04","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0000947871-26-000231","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2026-03-02","reportingPerson":"ORBIMED CAPITAL GP V LLC","reportingCik":"0001615374","personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-04","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0001172661-26-001163","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":null,"securityClass":"Common stock, par value $0.00001","eventDate":"2025-12-31","reportingPerson":"ArrowMark Colorado Holdings, LLC","reportingCik":null,"personType":"IA","sharesOwned":3090093,"percentOfClass":5.81,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0001373604-26-000014","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-12-31","reportingPerson":"BML Investment Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":5292000,"percentOfClass":9.9,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0001214659-25-016264","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":null,"securityClass":"Common stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"Sio Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":2636548,"percentOfClass":4.98,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0000947871-25-000926","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-10-23","reportingPerson":"ORBIMED ADVISORS LLC","reportingCik":"0001055951","personType":"IA","sharesOwned":4975291,"percentOfClass":9.4,"filedAt":"2025-10-27","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0000947871-25-000926","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-10-23","reportingPerson":"ORBIMED CAPITAL GP V LLC","reportingCik":"0001615374","personType":"OO","sharesOwned":4975291,"percentOfClass":9.4,"filedAt":"2025-10-27","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0001214659-25-014073","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-16","reportingPerson":"TANG CAPITAL MANAGEMENT, LLC","reportingCik":null,"personType":"OO","sharesOwned":4720357,"percentOfClass":8.9,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0001214659-25-014073","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-16","reportingPerson":"KEVIN TANG","reportingCik":null,"personType":"IN","sharesOwned":4720357,"percentOfClass":8.9,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0001214659-25-014073","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-16","reportingPerson":"TANG CAPITAL PARTNERS, LP","reportingCik":null,"personType":"PN","sharesOwned":2654728,"percentOfClass":5,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0001214659-25-014073","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-16","reportingPerson":"TANG CAPITAL PARTNERS INTERNATIONAL, LP","reportingCik":null,"personType":"PN","sharesOwned":2065629,"percentOfClass":3.9,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0001214659-25-014073","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-16","reportingPerson":"TANG CAPITAL PARTNERS III, INC","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"},{"accessionNo":"0001214659-25-014073","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001699382","issuerName":"PMV Pharmaceuticals, Inc.","ticker":"PMVP","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-16","reportingPerson":"TANG CAPITAL PARTNERS IV, INC","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp"}],"updatedAt":"2026-11-03T20:28:10.578Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/pmvp","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}